90 related articles for article (PubMed ID: 6093907)
1. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas.
Ulmann A; Brami M; Corcos D; Bader C; Delarue JC; Contesso G
Biomed Pharmacother; 1984; 38(4):204-8. PubMed ID: 6093907
[TBL] [Abstract][Full Text] [Related]
2. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D3 and breast cancer.
Eisman JA; Suva LJ; Frampton RJ
Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer.
Berger U; Wilson P; McClelland RA; Colston K; Haussler MR; Pike JW; Coombes RC
Cancer Res; 1987 Dec; 47(24 Pt 1):6793-9. PubMed ID: 2824042
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation.
Sato M; Hiragun A
J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC
Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
[TBL] [Abstract][Full Text] [Related]
8. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration.
Thomas GA; Simpson RU
Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543
[TBL] [Abstract][Full Text] [Related]
9. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
10. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells.
Freake HC; Iwasaki J; McCarthy DM
Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor.
Colston K; Wilkinson JR; Coombes RC
Endocrinology; 1986 Jul; 119(1):397-403. PubMed ID: 3013595
[TBL] [Abstract][Full Text] [Related]
14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 in the Atlantic cod: plasma levels, a plasma binding component, and organ distribution of a high affinity receptor.
Sundell K; Bishop JE; Björnsson BT; Norman AW
Endocrinology; 1992 Nov; 131(5):2279-86. PubMed ID: 1330497
[TBL] [Abstract][Full Text] [Related]
16. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes.
Provvedini DM; Rulot CM; Sobol RE; Tsoukas CD; Manolagas SC
J Bone Miner Res; 1987 Jun; 2(3):239-47. PubMed ID: 2843004
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus.
Kato A; Bishop JE; Norman AW
Biochem Biophys Res Commun; 1998 Mar; 244(3):724-7. PubMed ID: 9535732
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 1,25-dihydroxyvitamin D3 receptors and in vivo targeting of [3H]-1,25(OH)2D3 in the sheep placenta.
Ross R; Florer J; Halbert K; McIntyre L
Placenta; 1989; 10(6):553-67. PubMed ID: 2558376
[TBL] [Abstract][Full Text] [Related]
20. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.
Stern PH; Mavreas T; Tanaka Y; DeLuca HF; Ikekawa N; Kobayashi Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):9-13. PubMed ID: 6323693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
